Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E STARZL

Showing results (71-80 of 711) with videos related to

Pageof 72
Sort By:
Annals of Surgery|October 1, 1985
Role of liver transplantation in cancer therapyS Iwatsuki, R D Gordon, B W Shaw, et al.
Seminars in Liver Disease|February 24, 2001
The mystique of hepatic tolerogenicityT E Starzl, N Murase, A Demetris, et al.
Current Opinion in Nephrology and Hypertension|November 1, 1994
Chimerism after whole organ transplantation: its relationship to graft rejection and tolerance inductionA S Rao, A W Thomson, R Shapiro, et al.
The Journal of Surgical Research|July 1, 1990
Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemiaT R Walsh, P N Rao, L Makowka, et al.
Seminars in Liver Disease|November 1, 1985
Retransplantation of the liverB W Shaw, R D Gordon, S Iwatsuki, et al.
The American Journal of Pathology|March 1, 1975
Metabolic bone disease in chronic renal failure. II. Renal transplant patientsW E Huffer, D Kuzela, M M Popovtzer, et al.
Ciba Foundation Symposium|January 1, 1977
Portacaval shunt for glycogen storage disease and hyperlipidaemiaT E Starzl, C W Putnam, K A Porter, et al.
JAMA|July 1, 1983
Causes of death after kidney transplantationG F Washer, G P Schröter, T E Starzl, et al.
Lancet (London, England)|April 17, 1976
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogsT E Starzl, K Watanabe, K A Porter, et al.
Gastroenterology Clinics of North America|March 1, 1988
Liver transplantation for malignant tumorsB Koneru, A Cassavilla, J Bowman, et al.
Pageof 72

Showing results (71-80 of 711) with videos related to

Sort By:
Pageof 72
Annals of Surgery|October 1, 1985
Role of liver transplantation in cancer therapyS Iwatsuki, R D Gordon, B W Shaw, et al.
Seminars in Liver Disease|February 24, 2001
The mystique of hepatic tolerogenicityT E Starzl, N Murase, A Demetris, et al.
Current Opinion in Nephrology and Hypertension|November 1, 1994
Chimerism after whole organ transplantation: its relationship to graft rejection and tolerance inductionA S Rao, A W Thomson, R Shapiro, et al.
The Journal of Surgical Research|July 1, 1990
Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemiaT R Walsh, P N Rao, L Makowka, et al.
Seminars in Liver Disease|November 1, 1985
Retransplantation of the liverB W Shaw, R D Gordon, S Iwatsuki, et al.
The American Journal of Pathology|March 1, 1975
Metabolic bone disease in chronic renal failure. II. Renal transplant patientsW E Huffer, D Kuzela, M M Popovtzer, et al.
Ciba Foundation Symposium|January 1, 1977
Portacaval shunt for glycogen storage disease and hyperlipidaemiaT E Starzl, C W Putnam, K A Porter, et al.
JAMA|July 1, 1983
Causes of death after kidney transplantationG F Washer, G P Schröter, T E Starzl, et al.
Lancet (London, England)|April 17, 1976
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogsT E Starzl, K Watanabe, K A Porter, et al.
Gastroenterology Clinics of North America|March 1, 1988
Liver transplantation for malignant tumorsB Koneru, A Cassavilla, J Bowman, et al.
Pageof 72